# RNN 2nd Gen Model HCA Holdings, Inc. General medical & surgical hospitals

Stock predictor AI models:
Subscribe >> Deal exit on
Dec. 14, 2020
Deal entry on
Dec. 14, 2020
2.57%Expected margin
66.22% successful of 74 deals
$ 246.59 Last close price
at 18-oct-2021


Model's trade recommendations No return for period yet

-18.08% Annual return

$34.20B Market Cap

β 0.48  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period
52wk return -4.23%
52wk Range
Sortino ratio -0.53
Sharpe ratio -0.51
Norm. RMSE 3.31%
Downside risk 28.02%
Volatility 0.00%
  • 1.40 (1.43%) Div (Yield)
  • STRONG BUY Analysts consensus recommendation

HCA Inc. is a non-governmental hospital in the U.S. providing health care and related services. The Company operates a network of acute care hospitals, outpatient facilities, clinics and other patient care delivery settings. The Company also owns and manages freestanding surgery centers, diagnostic and imaging centers, radiation and oncology therapy centers, rehabilitation and physical therapy centers, and various other facilities. HCA Inc. is headquartered in Nashville, Tennessee.

Industry sector: Medical

Sector classification: General medical & surgical hospitals

Deep Learning based analysis and prediction model for HCA Holdings, Inc. (HCA) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 30, 2015.

Market data for HCA model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for HCA.

Model is being retrained on a regular basis.

Float 340M
P/E 13.19
Shares Outstanding 350M
% Held by Insiders 2.80%
% Held by Institutions 72.66%
EPS (last reported FY) $6.59
EPS (last reported Q) $2.33
EPS, estimated (last reported Q) $2.07
Total revenues $48 B
Net income $2 B